Most people in the developing world who have asthma, cystic fibrosis or other chronic lung diseases have no way to measure how well their lungs are functioning outside of a clinic or doctor visit. But many do have access to a phone, though it may be a 10-year-old flip phone or a communal village landline instead of the latest app-driven smartphone.
Answering the need for a solution to adress misuse and adherence issues of COPD inhalers, 3M Drug Delivery Systems has introduced the Intelligent Control Inhaler, an intuitive, fully-integrated device that delivers accurate doses to patients, whilst providing on-screen instructions for use and feedback to the patient and health care provider via an app.
In the framework of the exhibition organized by the Interest Group on Allergy and Asthma in the European Parliament on 26th-28th of April, EFA (MyAirCoach partner and dissemination manager) is pleased to invite you to an event where the results from EFA multiannual project will be presented as they relate to the identifications of the actual reasons for adolescents’ poor adherence to treatment.
The MyAirCoach project is organizing the Workshop on Mobile Healthcare for the Self-Management of Chronic Diseases and the Empowerment of Patients in Conjunction with MobileHCI 2016, Florence, Italy.
The world asthma congress has taken place this year in Madrid Spain. The continuous presence and increasing impact of the World Asthma Congress, underlines the importance of effective asthma management and reveals the importance of MyAirCoach objectives and innovation potential.
The Asthma Health project has been released alongside Apple's ResearchKit and aims at the creation of an innovative mobile phone application designed to facilitate asthma patient education and self-monitoring. In a recent development the Asthma Health project has been announced to expand in the United Kingdom and Ireland, taking an important step towards the promotion of mHealth technologies worldwide.
A new type of inhaler may be soon available, promising a significantly smaller and more convenient size.
The Bloom inhaler is about the size of a credit card and can be filled using any Hydrofluoroalkane inhaler and be kept in the patients wallet.
The Bloom inhaler is currently being tested for FDA approval and can be preordered online for a cost of $40
Google doodle today pays tribute to René Laennec. René-Théophile-Hyacinthe Laennec was a French physician. He invented the stethoscope in 1816, while working at the Hôpital Necker and pioneered its use in diagnosing various chest conditions. Link
Read more about the life and work of René Laennec. Link
Standardization is a crucial component of the MyAirCoah solution as it promises the fast and efficient integration of our solution with the global healthcare environment. In a recent article IEEE has focused on the standardization of eHealth technologies and identified that there has been a surge in IEEE standards activities in the health-care field. A new e-health standard was issued to protect biometric data exchanged via smartphones and similar devices.
MyAirCoach consortium member EFA has participated this December in the 27th conference on Drug Delivery on the Lungs in Edinburgh, Scotland. The conference gave a great oportunity for the dissemination of the MyAirCoach objectives and methodology and helped towards the understanding of the commercial and research environment of inhaled drug delivery.